Menlo Park-CA-(July 18, 2018) – Quantapore Inc. announced the completion of a $15.55 million sale of Series 3 Preferred Stock led by Northern Light Venture Capital (NLVC). Tsingyuan Ventures and Sangel Venture Capital were major investors in the round and … Read More
Until now, we have operated in stealth mode while we were developing this revolutionary way to sequence DNA and RNA. You’ll hear more from us in the coming months.
Menlo Park-CA-(Sep , 2016) – Quantapore Inc. today announced that it has closed a Series C financing round, led by China BioPharma Capital I, a venture capital fund advised by TVM Capital Life Science via its Hong Kong based office. … Read More
We are excited to support Martin and his highly experienced technical team … to further develop this cutting edge technology for the NGS market.